Insider filing · TVTX
Gary A Lyons
Director
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 74 filings in 24 months
ticker →
Gary A Lyons sold $543K of Travere Therapeutics (TVTX)
Executed Aug 17, disclosed Aug 19, 2 days later.
Value, as filed
$543K
8,600 sh across 3 lots
Executed
Aug 17
the trade date, as filed
Disclosed
Aug 19
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
GLGary A Lyons (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.3M of NBIX (15,000 sh × $152.61, as filed), executed Dec 3 2025.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Gary A Lyons in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$329K8,000 sh × $41.07
Exec Apr 14
Filed Apr 16 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $589K
40,000 sh across 2 lots
Exec Oct 4 2024
Filed Oct 4 2024 · 5:30 PM ET